Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer and Resistance Exercise Program (B-REP): A Feasibility and Acceptability Trial

NCT04562233 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT04562233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04562233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer and Resistance Exercise Program (B-REP): A Feasibility and Acceptability Trial
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Not applicable
Overall status
Terminated
Start date
December 1, 2020
Completion date
August 24, 2023
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, resistance training